-
1
-
-
0026493687
-
G19.4(alpha CD3) × B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4; 11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells
-
Anderson PM, Crist W, Hasz D, Carroll AJ, Myers DE, Uckun FM (1992) G19.4(alpha CD3) × B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4; 11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells. Blood 80:2826
-
(1992)
Blood
, vol.80
, pp. 2826
-
-
Anderson, P.M.1
Crist, W.2
Hasz, D.3
Carroll, A.J.4
Myers, D.E.5
Uckun, F.M.6
-
4
-
-
0028274563
-
Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 × anti-(tumour-associated antigen) bispecific antibody
-
Azuma A, Yagita H, Okumura K, Kudoh S, Niitani H (1994) Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 × anti-(tumour-associated antigen) bispecific antibody. Cancer Immunol Immunother 38:294
-
(1994)
Cancer Immunol Immunother
, vol.38
, pp. 294
-
-
Azuma, A.1
Yagita, H.2
Okumura, K.3
Kudoh, S.4
Niitani, H.5
-
5
-
-
0027281795
-
Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 × CD19 bispecific antibodies in combination with bivalent CD28 antibodies
-
Bohlen H, Hopff T, Manzke O, Engert A, Kube D, Wickramanayake PD, Diehl V, Tesch H (1993) Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 × CD19 bispecific antibodies in combination with bivalent CD28 antibodies. Blood 82:1803
-
(1993)
Blood
, vol.82
, pp. 1803
-
-
Bohlen, H.1
Hopff, T.2
Manzke, O.3
Engert, A.4
Kube, D.5
Wickramanayake, P.D.6
Diehl, V.7
Tesch, H.8
-
6
-
-
15644384495
-
Prevention of Epstein-Barr virus-induced human B cell lymphoma in severe combined immunodeficient mice treated with CD3 × CD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells
-
Bohlen H, Manzke O, Titzer S, Lorenzen J, Kube D, Engert A, Abken H, Wolf J, Diehl V, Tesch H (1997) Prevention of Epstein-Barr virus-induced human B cell lymphoma in severe combined immunodeficient mice treated with CD3 × CD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells. Cancer Res 57:1704
-
(1997)
Cancer Res
, vol.57
, pp. 1704
-
-
Bohlen, H.1
Manzke, O.2
Titzer, S.3
Lorenzen, J.4
Kube, D.5
Engert, A.6
Abken, H.7
Wolf, J.8
Diehl, V.9
Tesch, H.10
-
8
-
-
84987566186
-
Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumour cell lysis by cytotoxic T cells
-
Canevari S, Menard S, Mezzanzanica D, Miotti S, Pupa SM, Lanzavecchia A, Colnaghi MI (1988) Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumour cell lysis by cytotoxic T cells . Int J Cancer [Suppl] 2:18
-
(1988)
Int J Cancer [Suppl]
, vol.2
, pp. 18
-
-
Canevari, S.1
Menard, S.2
Mezzanzanica, D.3
Miotti, S.4
Pupa, S.M.5
Lanzavecchia, A.6
Colnaghi, M.I.7
-
9
-
-
0028152942
-
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells
-
Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J (1994) B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 180:1841
-
(1994)
J Exp Med
, vol.180
, pp. 1841
-
-
Caux, C.1
Vanbervliet, B.2
Massacrier, C.3
Azuma, M.4
Okumura, K.5
Lanier, L.L.6
Banchereau, J.7
-
10
-
-
0028882034
-
In vivo studies using bispecific antibodies (anti-CD3 × anti-idiotype) and CD28-induced costimulation in the BCL1 lymphoma
-
Demanet C, Brissinck J, De Jonge J, Thielemans K (1995) In vivo studies using bispecific antibodies (anti-CD3 × anti-idiotype) and CD28-induced costimulation in the BCL1 lymphoma. J Hematother 4:363
-
(1995)
J Hematother
, vol.4
, pp. 363
-
-
Demanet, C.1
Brissinck, J.2
De Jonge, J.3
Thielemans, K.4
-
11
-
-
0027142545
-
Targeting of T lymphocytes against EGF-receptor+ tumour cells by bispecific monoclonal antibodies: Requirement of CD3 molecule cross-linking for T cell activiation
-
Ferrini S, Cambiaggi A, Sforzini S, Marciano S, Canevari S, Mezzanzanica D, Colnaghi MI, Grossi CE, Moretta L (1993) Targeting of T lymphocytes against EGF-receptor+ tumour cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T cell activiation. Int J Cancer 55:931
-
(1993)
Int J Cancer
, vol.55
, pp. 931
-
-
Ferrini, S.1
Cambiaggi, A.2
Sforzini, S.3
Marciano, S.4
Canevari, S.5
Mezzanzanica, D.6
Colnaghi, M.I.7
Grossi, C.E.8
Moretta, L.9
-
12
-
-
0028844025
-
Performance of CD3 × CD19 bispecific monoclonal antibodies in B cell malignancy
-
Haagen IA (1995) Performance of CD3 × CD19 bispecific monoclonal antibodies in B cell malignancy. Leuk Lymphoma 19:381
-
(1995)
Leuk Lymphoma
, vol.19
, pp. 381
-
-
Haagen, I.A.1
-
13
-
-
0026537347
-
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
-
Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607
-
(1992)
Nature
, vol.356
, pp. 607
-
-
Harding, F.A.1
McArthur, J.G.2
Gross, J.A.3
Raulet, D.H.4
Allison, J.P.5
-
14
-
-
0028337459
-
Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function
-
Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180:631
-
(1994)
J Exp Med
, vol.180
, pp. 631
-
-
Hathcock, K.S.1
Laszlo, G.2
Pucillo, C.3
Linsley, P.4
Hodes, R.J.5
-
15
-
-
0027358685
-
A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo
-
Hombach A, Jung W, Pohl C, Renner C, Sahin U, Schmits R, Wolf J. Kapp U, Diehl V, Pfreundschuh M (1993) A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo. Int J Cancer 55:830
-
(1993)
Int J Cancer
, vol.55
, pp. 830
-
-
Hombach, A.1
Jung, W.2
Pohl, C.3
Renner, C.4
Sahin, U.5
Schmits, R.6
Wolf, J.7
Kapp, U.8
Diehl, V.9
Pfreundschuh, M.10
-
16
-
-
0027427657
-
Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells
-
Kroesen BJ, ter Haar A, Spakman H, Willemse P, Sleijfer DT, de Vries EG, Mulder NH. Berendsen HH, Limburg PC, The TH, de Leij L, (1993) Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells. Cancer Immunol Immunother 37:400
-
(1993)
Cancer Immunol Immunother
, vol.37
, pp. 400
-
-
Kroesen, B.J.1
Ter Haar, A.2
Spakman, H.3
Willemse, P.4
Sleijfer, D.T.5
De Vries, E.G.6
Mulder, N.H.7
Berendsen, H.H.8
Limburg, P.C.9
The, T.H.10
De Leij, L.11
-
17
-
-
0028122745
-
Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2
-
Kroesen BJ, Buter J, Sleijfer DT, Janssen RA, van der Graaf W, The TH, de Leij L, Mulder NH (1994) Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2. Br J Cancer 70:652
-
(1994)
Br J Cancer
, vol.70
, pp. 652
-
-
Kroesen, B.J.1
Buter, J.2
Sleijfer, D.T.3
Janssen, R.A.4
Van Der Graaf, W.5
The, T.H.6
De Leij, L.7
Mulder, N.H.8
-
18
-
-
0026758014
-
Human cytotoxic T lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion
-
Luna-Fineman S, Lee JE, Wesley PK, Clayberger C, Krensky AM (1992) Human cytotoxic T lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion. Cancer 70:2181
-
(1992)
Cancer
, vol.70
, pp. 2181
-
-
Luna-Fineman, S.1
Lee, J.E.2
Wesley, P.K.3
Clayberger, C.4
Krensky, A.M.5
-
19
-
-
0031444874
-
Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic introduction chromatography
-
in press
-
Manzke O, Tesch H, Diehl V, Bohlen H (1997) Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic introduction chromatography. Journal of Immunological Methods (in press)
-
(1997)
Journal of Immunological Methods
-
-
Manzke, O.1
Tesch, H.2
Diehl, V.3
Bohlen, H.4
-
20
-
-
0020518331
-
Hybrid hybridomas and their use in immunohistochemistry
-
Milstein C, Cuello AC (1983) Hybrid hybridomas and their use in immunohistochemistry. Nature 305:537
-
(1983)
Nature
, vol.305
, pp. 537
-
-
Milstein, C.1
Cuello, A.C.2
-
21
-
-
0025161953
-
Preliminary trial of specific targeting therapy against malignant glioma
-
Nitta T, Sato K, Yagita H, Okumura K, Ishii S (1990) Preliminary trial of specific targeting therapy against malignant glioma. Lancet 335:368
-
(1990)
Lancet
, vol.335
, pp. 368
-
-
Nitta, T.1
Sato, K.2
Yagita, H.3
Okumura, K.4
Ishii, S.5
-
22
-
-
0027165746
-
Tolerance and ways to break it
-
Nossal GJ (1993) Tolerance and ways to break it. Ann N Y Acad Sci 690:34
-
(1993)
Ann N Y Acad Sci
, vol.690
, pp. 34
-
-
Nossal, G.J.1
-
23
-
-
0026016673
-
Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab′ antibody cross-linked to anti-CD10 Fab′ antibody
-
Oshimi K, Seto T, Oshimi Y, Masuda M, Okumura K, Mizoguchi H (1991) Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab′ antibody cross-linked to anti-CD10 Fab′ antibody. Blood 77:1044
-
(1991)
Blood
, vol.77
, pp. 1044
-
-
Oshimi, K.1
Seto, T.2
Oshimi, Y.3
Masuda, M.4
Okumura, K.5
Mizoguchi, H.6
-
24
-
-
0024519173
-
Induction of tumour-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen
-
van Dijk J, Warnaar SO, van Eendenburg J, van DJ, Warnaar SO, van EJ, Thienpont M, Braakman E, Boot JH, Fleuren GJ, Bolhuis RL (1989) Induction of tumour-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen. Int J Cancer 43:344
-
(1989)
Int J Cancer
, vol.43
, pp. 344
-
-
Van Dijk, J.1
Warnaar, S.O.2
Van Eendenburg, J.3
Van, D.J.4
Warnaar, S.O.5
Van, E.J.6
Thienpont, M.7
Braakman, E.8
Boot, J.H.9
Fleuren, G.J.10
Bolhuis, R.L.11
-
25
-
-
0028800647
-
Bispecific monoclonal antibody therapy of B-cell malignancy
-
Weiner GJ, De Gast GC (1995) Bispecific monoclonal antibody therapy of B-cell malignancy. Leuk Lymphoma 16:199
-
(1995)
Leuk Lymphoma
, vol.16
, pp. 199
-
-
Weiner, G.J.1
De Gast, G.C.2
-
26
-
-
0024391086
-
Characterization of the CD4+ and CD8+ tumour-infiltratin lymphocytes propagated with bispecific monoclonal antibodies
-
Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL (1989) Characterization of the CD4+ and CD8+ tumour-infiltratin lymphocytes propagated with bispecific monoclonal antibodies. J Immunol 143:3404
-
(1989)
J Immunol
, vol.143
, pp. 3404
-
-
Wong, J.T.1
Pinto, C.E.2
Gifford, J.D.3
Kurnick, J.T.4
Kradin, R.L.5
-
27
-
-
0021227328
-
A cloned T cell line cytotoxic for autologous and allogeneic B lymphoma cells
-
Yssel H, Spits H, De Vries J (1984) A cloned T cell line cytotoxic for autologous and allogeneic B lymphoma cells. J Exp Med 160:239
-
(1984)
J Exp Med
, vol.160
, pp. 239
-
-
Yssel, H.1
Spits, H.2
De Vries, J.3
|